Journal Article

Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers

Saroul, Nicolas, Pham-Dang, Nathalie, Durando, Xavier, Bernadach, Maureen, Dillies, Anne-Françoise, Molnar, Ioana, Lapeyre, Michel, Miroir, Jessica, Moreau, Juliette, Casile, Melanie, Biau, Julian, Ginzac, Angeline

2021

Overview

Background The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however highly effective in terms of rate and speed of response. The purpose of the study was to investigate predictive factors of toxicity of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) in locally advanced head and neck cancers (LAHNC). Methods Between June 2009 and December 2017, 113 patients treated consecutively with TPF were included retrospectively. Patients were receiving induction chemotherapy for either an inoperable cancer or laryngeal preservation. For inoperable cancer, induction chemotherapy was proposed to patients presenting either a large tumor with strong symptoms (dyspnea, dysphagia, pain) or a tumor with rapid progression. Risk factors were chosen among the initial patient and tumour characteristics and chemotherapy modalities. Results Eighty-nine patients (79%) were male; the median age was 58 years [32–71]. Sixty-nine (61%) patients were treated for inoperable cancer and 44 (39%) for laryngeal preservation. 45% had stage IVa cancer, 28% stage III and 25% stage IVb. Sixty percent of patients had a partial response after TPF, 22% had a complete response, 12% were stable, 5% were progressing, and 1% had a discordant response. Thirty-four patients (30%) received enteral feeding during induction chemotherapy with TPF. The possibility of oral feeding without a tube was predictive of a better response ( p  = 0.003). Seven (6%) patients died during TPF. There was an increased risk of death with preexisting liver dysfunction (liver dysmorphia on imaging or decrease prothrombin rate) ( p  = 0.032). There was an increased risk of grade ≥ 3 infection if an enteral feeding occurred during the period of induction chemotherapy (p = 0.03). Conclusions TPF induction chemotherapy had an 82% objective response rate with 6% toxic deaths. Nutritional status and the presence of hepatic dysfunction are significant risk factors to be taken into account in therapeutic decisions.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: 5-Fluorouracil / Adult / Aged / Antineoplastic Combined Chemotherapy Protocols - pharmacology / Antineoplastic Combined Chemotherapy Protocols - therapeutic use / Biomedical and Life Sciences / Biomedicine / Cancer / Cancer Research / Cancer therapies / Chemotherapy / Cisplatin / Cisplatin - pharmacology / Cisplatin - therapeutic use / Complications and side effects / Disease prevention / Docetaxel / Drug therapy / Drugs / Dysphagia / Dyspnea / Enteral feeding / Female / Fluorouracil / Fluorouracil - pharmacology / Fluorouracil - therapeutic use / Head & neck cancer / Head and neck cancer / Head and Neck Neoplasms - drug therapy / Health aspects / Health Promotion and Disease Prevention / Hepatic dysfunction / Humans / Hypothesis testing / Induction chemotherapy / Induction Chemotherapy - methods / Life Sciences / Liver diseases / Liver failure / Male / Medicine/Public Health / Middle Aged / Nutritional status / Oncology / Patients / Preservation / Prothrombin / Radiation therapy / Research Article / Respiration / Risk factors / Surgical Oncology / Taxoids - pharmacology / Taxoids - therapeutic use / Toxicity / TPF / Tumors